In 2023, Huang et al. [40] pointed out that TGF-β/Smad signaling pathway is the upstream pathway mediating RUNX3 nuclear import in tumor models, and nuclear RUNX3 has a negative regulatory mechanism on TGF-β/Smad pathway. Here, RUNX3 is linked to neoplasm.